title: ACE-inhibitors versus angiotensin receptor blockers for renoprotection: conclusions from the evidence and from the evidence behind the evidence.
authors.forename: W
authors.initials: W
authors.lastname: Van Biesen
authors.forename: B
authors.initials: B
authors.lastname: Van Vlem
authors.forename: H
authors.initials: H
authors.lastname: Schepkens
authors.forename: N
authors.initials: N
authors.lastname: Lameire
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D051437:Renal Insufficiency / Q000188:drug therapy* / Q000517:prevention & control*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors